Pathological complete response (pCR) with or without the residual intraductal carcinoma component following preoperative treatment for pancreatic cancer: Revisiting the definition of “pCR” from the prognostic standpoint

Pathological complete response (pCR) with or without the residual intraductal carcinoma component following preoperative treatment for pancreatic cancer: Revisiting the definition of “pCR” from the prognostic standpoint

Abstract Background and Aim There are no previous reports describing the prognostic significance of the residual intraductal carcinoma component (carcinoma in situ [CIS]) following preoperative treatment for pancreatic ductal adenocarcinoma (PDAC). The aim of the present study was to investigate the...

Full description

Bibliographic Details
Main Authors: Daisaku Yamada, Hidenori Takahashi, Kei Asukai, Shinichiro Hasegawa, Akira Tomokuni, Hiroshi Wada, Hirofumi Akita, Masayohi Yasui, Hiroshi Miyata, Osamu Ishikawa
Format: Article
Language:English
Published: Wiley 2019-11-01
Series:Annals of Gastroenterological Surgery
Subjects:
intraductal carcinoma component
pancreatic ductal adenocarcinoma
pathological complete response
Online Access:https://doi.org/10.1002/ags3.12288

Internet

https://doi.org/10.1002/ags3.12288

Similar Items